Literature DB >> 11056035

Covariance analysis of protein families: the case of the variable domains of antibodies.

L Choulier1, V Lafont, N Hugo, D Altschuh.   

Abstract

A nonrestrictive method for identifying covariance in protein families is described and applied to human and mouse germline Vkappa and VH sequence alignments. Amino acids that occur at each position in a sequence alignment are divided into two sets, called a word, by generating all possible combinations of alternative amino acids. Each word is associated with a pattern of changes. Words with identical patterns identify covariant positions. In antibody variable domains, the number of words generated ranged between 1103 and 2195 depending on the alignment, of which 4 to 12 % occurred in covariant pairs. Despite the nonrestrictive character of pattern generation, covariant residues did not reflect a random selection with respect to the nature of amino acid changes and/or their spatial proximity in a reference crystallographic structure. This approach allowed the identification of a covariance signal for positions with high variability, mostly located in the outer part of the common structural framework of antibody variable domains. Covariance in these regions may reflect the existence of alternative and mutually exclusive atomic arrangements that are compatible with antibody function. The method may be of general applicability to rationalize residue variability in protein families.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056035     DOI: 10.1002/1097-0134(20001201)41:4<475::aid-prot50>3.0.co;2-g

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  2 in total

1.  Functional aspects of co-variant surface charges in an antibody fragment.

Authors:  Nicolas Hugo; Virginie Lafont; Mervyn Beukes; Danièle Altschuh
Journal:  Protein Sci       Date:  2002-11       Impact factor: 6.725

2.  Development of scoring functions for antibody sequence assessment and optimization.

Authors:  Daniel Seeliger
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.